Literature DB >> 29710088

Safety of Osteopathic Cranial Manipulative Medicine as an Adjunct to Conventional Postconcussion Symptom Management: A Pilot Study.

Komal G Patel, Rosanna C Sabini.   

Abstract

CONTEXT: Osteopathic cranial manipulative medicine is not a well-established adjunct to conventional treatment for patients with postconcussion symptoms.
OBJECTIVE: To determine whether adjunctive osteopathic cranial manipulative medicine is safe for patients with concussion when accompanied by conventional treatments.
DESIGN: Prospective observational pilot study.
SETTING: Outpatient concussion clinic. PARTICIPANTS: Patients who sustained a concussion were prospectively recruited from an outpatient concussion clinic by a neuropsychologist specialized in concussion. All participants were identified to have a cranial dysfunction. INTERVENTION: Each eligible participant received 1 session of the osteopathic cranial manipulative medicine vault hold technique. MAIN OUTCOME MEASURES: Self-reported adverse events during or after 1 session of the osteopathic cranial manipulative medicine procedure and improvement in concussion symptoms at return to follow-up.
RESULTS: None of the 9 participants reported adverse events during or immediately after receiving osteopathic cranial manipulative medicine. Five of the 7 participants who returned for follow-up demonstrated improvement in their overall concussion symptoms based on the Post-Concussion Symptom Scale scores.
CONCLUSIONS: Osteopathic cranial manipulative medicine was considered a safe adjunctive treatment option to improve concussion-related symptoms and recovery.

Entities:  

Mesh:

Year:  2018        PMID: 29710088     DOI: 10.7556/jaoa.2018.061

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  1 in total

Review 1.  A Review of Glymphatics and the Impact of Osteopathic Manipulative Treatment in Alzheimer's Disease, Concussions, and Beyond.

Authors:  Maxwell A Marino; Sarah Petrova; Raed Sweiss; Jason Duong; Dan E Miulli
Journal:  Cureus       Date:  2022-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.